Publications Database

Akhondzadeh S. et al. (2008)

A double-blind placebo controlled trial of piracetam added to risperidone in patients with autistic disorder.

Child Psychiatry and Human Development

39(3), pp. 237-245

Read Abstract (New Window)

Akhondzadeh S. et al. (2010)

Double-blind placebo controlled trial of pentoxifylline added to risperidone: Effects on aberrant behavior in children with autism.

Progress in Neuro-Psychopharmacology and Biological Psychiatry

34(1), pp. 32-36

Read Abstract (New Window)

Alexander R. , Michael D. , Ganghadaran S. (2004)

The use of risperidone in adults with Asperger syndrome.

British Journal of Learning Disabilities

50(99), pp. 109-115.

Read Abstract (New Window)

Ali G. et al. (2016)

Minocycline as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind placebo-controlled trial.

Journal of Child and Adolescent Psychopharmacology

November, 26(9), pp. 784-791.

Read Abstract (New Window)

Aman M. G. et al. (2005)

Acute and long-term safety and tolerability of risperidone in children with autism.

Journal of Child and Adolescent Psychopharmacology

15(6), pp. 869-884

Read Abstract (New Window)

Aman M. G. et al. (2008)

Cognitive effects of risperidone in children with autism and irritable behavior.

Journal of Child and Adolescent Psychopharmacology

18(3), pp. 227-236

Read Abstract (New Window) Read Full (New Window)

Aman M. G. et al. (2009)

Medication and parent training in children with pervasive developmental disorders and serious behavior problems: Results from a randomized clinical trial.

Journal of the American Academy of Child and Adolescent Psychiatry

48(12), pp. 1143-1154

Read Abstract (New Window) Read Full (New Window)

Aman M. G. et al. (2015)

Tolerability, safety, and benefits of risperidone in children and adolescents with autism: 21-month follow-up after 8-week placebo-controlled trial.

Journal of Child and Adolescent Psychopharmacology

August, 25(6), pp. 482-493.

Read Abstract (New Window) Read Full (New Window)

American Society of Health-System Pharmacists (2017)

Risperidone.

Bethesda, MD: American Society of Health-System Pharmacists

Read Full (New Window)

Anagnostou E.

Clinical trials in autism spectrum disorder: evidence, challenges and future directions.

Current Opinion in Neurology

Read Abstract (New Window)

Anderson G. M. et al. (2007)

Effects of short- and long-term risperidone treatment on prolactin levels in children with autism.

February, 61(4), pp. 545-550.

Read Abstract (New Window)

Arnold L. E. et al. (2000)

Assessment in multisite randomized clinical trials of patients with autistic disorder: the Autism RUPP Network.

Journal of Autism and Developmental Disorders

April, 30(2), pp. 99–111

Read Abstract (New Window)

Arnold L. E. et al. (2003)

Parent-defined target symptoms respond to risperidone in RUPP autism study: customer approach to clinical trials.

Journal of the American Academy of Child and Adolescent Psychiatry

42(12), pp. 1443-1450

Read Abstract (New Window)

Arnold L. E. et al. (2012)

Research Units of Pediatric Psychopharmacology (RUPP) Autism Network randomized clinical trial of parent training and medication: One-year follow-up.

Journal of the American Academy of Child and Adolescent Psychiatry

51(11), pp. 1173-1184.

Read Abstract (New Window) Read Full (New Window)

Asadabadi M. et al. (2013)

Celecoxib as adjunctive treatment to risperidone in children with autistic disorder: a randomized, double-blind, placebo-controlled trial.

Psychopharmacology (Berl)

225(1), pp. 51-59.

Read Abstract (New Window)

Bachmann C. J. et al. (2013)

Psychopharmacological treatment in children and adolescents with autism spectrum disorders in Germany.

Research in Developmental Disabilities

June, 34(9), pp. 2551-2563.

Read Abstract (New Window)

Baribeau D. A. , Anagnostou E. (2014)

An update on medication management of behavioral disorders in autism.

Current Psychiatry Reports

16(3), pp. 437

Read Abstract (New Window)

Barnard A. L. et al. (2002)

A systematic review of the use of atypical antipsychotics in autism.

Journal of Psychopharmacology

16(1), pp. 93-101

Read Abstract (New Window)

Boon-Yasidhi V. et al. (2002)

Risperidone in the treatment of autistic Thai children under 4 years of age.

Journal of the Medical Association of Thailand

85 s. 784-789

Read Abstract (New Window)

Caccia S. (2013)

Safety and pharmacokinetics of atypical antipsychotics in children and adolescents.

Pediatric Drugs

15(3), pp. 217-233.

Read Abstract (New Window)